Basit öğe kaydını göster

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

dc.contributor.authorAlessio, M
dc.contributor.authorRuperto, N
dc.contributor.authorMurray, KJ
dc.contributor.authorGerloni, V
dc.contributor.authorWulffraat, N
dc.contributor.authorde Oliveira, SKF
dc.contributor.authorFalcini, F
dc.contributor.authorDolezalova, P
dc.contributor.authorBurgos-Vargas, R
dc.contributor.authorCorona, F
dc.contributor.authorVesely, R
dc.contributor.authorFoster, H
dc.contributor.authorDavidson, J
dc.contributor.authorZulian, F
dc.contributor.authorAsplin, L
dc.contributor.authorBaildam, E
dc.contributor.authorConsuegra, JG
dc.contributor.authorOzdogan, H
dc.contributor.authorSaurenmann, R
dc.contributor.authorJoos, R
dc.contributor.authorPistorio, A
dc.contributor.authorWoo, P
dc.contributor.authorMartini, A
dc.date.accessioned2021-03-03T10:55:48Z
dc.date.available2021-03-03T10:55:48Z
dc.date.issued2004
dc.identifier.citationRuperto N., Murray K., Gerloni V., Wulffraat N., de Oliveira S., Falcini F., Dolezalova P., Alessio M., Burgos-Vargas R., Corona F., et al., "A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate", ARTHRITIS AND RHEUMATISM, cilt.50, sa.7, ss.2191-2201, 2004
dc.identifier.issn0004-3591
dc.identifier.otherav_2562a924-17b5-47b8-8f84-d1927111bd94
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/30026
dc.identifier.urihttps://doi.org/10.1002/art.20288
dc.description.abstractObjective. To compare the safety and efficacy of parenteral methotrexate (MTX) at an intermediate dosage (15mg/m(2)/week) versus a higher dosage (30 mg/m(2)/ week) in patients with polyarticular-course juvenile idiopathic arthritis (JIA) who failed to improve while receiving standard dosages of MTX (8-12.5 mg/m(2)/ week).
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.titleA randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate
dc.typeMakale
dc.relation.journalARTHRITIS AND RHEUMATISM
dc.contributor.department, ,
dc.identifier.volume50
dc.identifier.issue7
dc.identifier.startpage2191
dc.identifier.endpage2201
dc.contributor.firstauthorID172172


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster